Products for Research Use Only
RegisterLogin

Burfiralimab

CAT: 0804-HY-P99490-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99490-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Burfiralimab (hzVSF-v13) is a monoclonal IgG4 antibody against vimentin expressed on the surface of virus-infected cells, with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation. Burfiralimab can be used in severe COVID-19 studies[1].
CAS Number
2460809-80-5
Product Name Alternative
HzVSF-v13
UNSPSC
12352203
Target
Interleukin Related; SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection; Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/burfiralimab.html
Purity
95.20
Solubility
10 mM in DMSO
Smiles
[Burfiralimab]
Molecular Weight
(144.6 kDa)
References & Citations
[1]Prasenohadi Prasenohadi, et al. Double-Blind, Randomized, Placebo-Controlled Study on hzVSF-v13, a Novel Anti-Vimentin Monoclonal Antibody Drug as Add-on Standard of Care in the Management of Patients with Moderate to Severe COVID-19. J Clin Med. 2022 May 24;11 (11) :2961.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
abx831731-01Burfiralimab
GTR18337833-01Burfiralimab Antibody
WA2562Research Grade Burfiralimab
E55B0878Burfiralimab (Reference antibody)
A138273Burfiralimab Biosimilar (Monoclonal, IgG4)
ICH5232-10mgBurfiralimab Biosimilar - Research Grade
GTR18780456-01(Burfiralimab) Biosimilar Reference Antibody
GTR18697236-01Burfiralimab Human Monoclonal Antibody
E24CHB568Anti-Vimentin Reference Antibody (burfiralimab)
A135602Burfiralimab Biosimilar (Monoclonal, IgG4-kappa)

Popular Products